These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19640716)

  • 1. Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4).
    Williams R; Johnson KA; Gentry PR; Niswender CM; Weaver CD; Conn PJ; Lindsley CW; Hopkins CR
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4967-70. PubMed ID: 19640716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the active conformation of cyclohexane carboxylate positive allosteric modulators of the type 4 metabotropic glutamate receptor.
    Rovira X; Harrak Y; Trapero A; González-Bulnes P; Malhaire F; Pin JP; Goudet C; Giraldo J; Llebaria A
    ChemMedChem; 2014 Dec; 9(12):2685-98. PubMed ID: 25196639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia.
    Bennouar KE; Uberti MA; Melon C; Bacolod MD; Jimenez HN; Cajina M; Kerkerian-Le Goff L; Doller D; Gubellini P
    Neuropharmacology; 2013 Mar; 66():158-69. PubMed ID: 22491024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4.
    Niswender CM; Johnson KA; Weaver CD; Jones CK; Xiang Z; Luo Q; Rodriguez AL; Marlo JE; de Paulis T; Thompson AD; Days EL; Nalywajko T; Austin CA; Williams MB; Ayala JE; Williams R; Lindsley CW; Conn PJ
    Mol Pharmacol; 2008 Nov; 74(5):1345-58. PubMed ID: 18664603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulators.
    Niswender CM; Lebois EP; Luo Q; Kim K; Muchalski H; Yin H; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5626-30. PubMed ID: 18793851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal metabotropic glutamate receptor 4 is involved in neuropathic pain.
    Wang H; Jiang W; Yang R; Li Y
    Neuroreport; 2011 Mar; 22(5):244-8. PubMed ID: 21358553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's disease.
    Le Poul E; Boléa C; Girard F; Poli S; Charvin D; Campo B; Bortoli J; Bessif A; Luo B; Koser AJ; Hodge LM; Smith KM; DiLella AG; Liverton N; Hess F; Browne SE; Reynolds IJ
    J Pharmacol Exp Ther; 2012 Oct; 343(1):167-77. PubMed ID: 22787118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: ultrastructural localization and electrophysiological effects of activation in the striatopallidal complex.
    Bogenpohl J; Galvan A; Hu X; Wichmann T; Smith Y
    Neuropharmacology; 2013 Mar; 66():242-52. PubMed ID: 22634360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). Part II: Challenges in hit-to-lead.
    Williams R; Niswender CM; Luo Q; Le U; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2009 Feb; 19(3):962-6. PubMed ID: 19097893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of metabotropic glutamate receptor 4 regulates proliferation and neural differentiation in neural stem/progenitor cells of the rat subventricular zone and increases phosphatase and tensin homolog protein expression.
    Zhang Z; Zheng X; Liu Y; Luan Y; Wang L; Zhao L; Zhang J; Tian Y; Lu H; Chen X; Liu Y
    J Neurochem; 2021 Feb; 156(4):465-480. PubMed ID: 32052426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping binding sites drive allosteric agonism and positive cooperativity in type 4 metabotropic glutamate receptors.
    Rovira X; Malhaire F; Scholler P; Rodrigo J; Gonzalez-Bulnes P; Llebaria A; Pin JP; Giraldo J; Goudet C
    FASEB J; 2015 Jan; 29(1):116-30. PubMed ID: 25342125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in the development of mGluR4 positive allosteric modulators for the treatment of Parkinson's disease.
    Lindsley CW; Niswender CM; Engers DW; Hopkins CR
    Curr Top Med Chem; 2009; 9(10):949-63. PubMed ID: 19754407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric modulation of the group III mGlu4 receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson's disease.
    Betts MJ; O'Neill MJ; Duty S
    Br J Pharmacol; 2012 Aug; 166(8):2317-30. PubMed ID: 22404342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers.
    Niswender CM; Jones CK; Lin X; Bubser M; Thompson Gray A; Blobaum AL; Engers DW; Rodriguez AL; Loch MT; Daniels JS; Lindsley CW; Hopkins CR; Javitch JA; Conn PJ
    ACS Chem Neurosci; 2016 Sep; 7(9):1201-11. PubMed ID: 27441572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mGluR4-positive allosteric modulation as potential treatment for Parkinson's disease.
    Hopkins CR; Lindsley CW; Niswender CM
    Future Med Chem; 2009 Jun; 1(3):501-13. PubMed ID: 20161443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and optimization of a novel CNS penetrant series of mGlu
    Kent CN; Fulton MG; Stillwell KJ; Dickerson JW; Loch MT; Rodriguez AL; Blobaum AL; Boutaud O; Rook JL; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2021 Apr; 37():127838. PubMed ID: 33556572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated synthetic, pharmacological, and computational investigation of cis-2-(3,5-dichlorophenylcarbamoyl)cyclohexanecarboxylic acid enantiomers as positive allosteric modulators of metabotropic glutamate receptor subtype 4.
    Christov C; González-Bulnes P; Malhaire F; Karabencheva T; Goudet C; Pin JP; Llebaria A; Giraldo J
    ChemMedChem; 2011 Jan; 6(1):131-40. PubMed ID: 21132834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold.
    Sharma S; Rodriguez AL; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4098-101. PubMed ID: 18550372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHA.
    Zhao Z; Wisnoski DD; O'Brien JA; Lemaire W; Williams DL; Jacobson MA; Wittman M; Ha SN; Schaffhauser H; Sur C; Pettibone DJ; Duggan ME; Conn PJ; Hartman GD; Lindsley CW
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1386-91. PubMed ID: 17210250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of type 4 metabotropic glutamate receptor promotes cell apoptosis and inhibits proliferation in bladder cancer.
    Zhang Z; Liu Y; Wang K; Zhu K; Zheng X; Wang L; Luan Y; Wang X; Lu H; Wu K; Chen X; He D; Liu Y
    J Cell Physiol; 2019 Mar; 234(3):2741-2755. PubMed ID: 30145816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.